Canadian urological association

The Canadian Urological Association CUA does not provide professional medical advice, diagnosis or treatment and cannot respond to requests canadian urological association direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition.

Federal government websites often end in. The site is secure. As we exited the pandemic, healthcare within Canada was forced to take stock of the unmet clinical care needs and assign priorities to address those demands. In order to best assist our members and their patients as we faced the post-pandemic new world order, CUA leadership felt it important to obtain the most updated information on the current state of urology in Canada. To that end, a census was developed and circulated to the CUA membership. The intention was to collect data on membership demographics and practice patterns, as well as to better understand workforce and resource challenges across the country. Moreover, it was hoped that the information obtained could be used by the CUA in its advocacy efforts with licensing, accrediting bodies, and policymakers.

Canadian urological association

Federal government websites often end in. The site is secure. Prostate cancer remains the most commonly diagnosed non-cutaneous malignancy among Canadian men and is the third leading cause of cancer-related death. In , an estimated 21 men were diagnosed with prostate cancer and men died from the disease; 1 however, prostate cancer is a heterogeneous disease with a clinical course ranging from indolent to life-threatening. Identifying and treating men with clinically significant prostate cancer while avoiding the over-diagnosis and over-treatment of indolent disease remains a significant challenge. Several professional associations have developed guidelines on prostate cancer screening and early diagnosis, but there are conflicting recommendations on how best to approach these issues. With recent updates from several large, randomized, prospective trials, as well as the emergence of several new diagnostic tests, the Canadian Urological Association CUA has developed these evidence-based recommendations to guide clinicians on prostate cancer screening and early diagnosis for Canadian men. The aim of these recommendations is to provide guidance on the current best prostate cancer screening and early diagnosis practices and to provide information on new and emerging diagnostic modalities. In order to develop these recommendations, the following questions related to prostate cancer screening and diagnosis were defined, a priori, to guide the specific literature searches and evidence synthesis:. The aim of answering the first four questions is to provide guidance on prostate cancer screening in general.

Percentage of respondents with access to specialized services, including by region. Zlotta, Brant Inman, Peter C. Men undergoing screening should be involved in the decision-making regarding prostate biopsy, canadian urological association.

McMaster Institute of Urology at St. Published: Robotic-assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction A retrospective review of a high-volume Canadian center Michael Ordon, Aren Mnatzakanian, Melody Djuimo, R. Vangala, Mohammed Bassuony, Ahmed S. Zakaria, Walid Shahrour, Hazem Elmansy.

Federal government websites often end in. The site is secure. Preview improvements coming to the PMC website in October Learn More or Try it out now. It is well-described that neurological disorders can lead to urological complications, including: urinary incontinence, urinary tract infections UTIs , urolithiasis, sepsis, ureteric obstruction, vesicoureteric reflux VUR , and renal failure. Despite the frequency and potential severity of NLUTD, there are few high-quality studies in the literature to guide urological practices. Prior neurogenic guidelines vary in their clinical assessment, investigations used, and surveillance strategies. The etiology of a NLUTD is often classified based on whether the primary lesion is suprapontine, suprasacral, sacral, or infrasacral. Newer systems using magnetic resonance MR urography in combination with urodynamics UDS have also been proposed.

Canadian urological association

Laurence H. In , CUAJ became a bimonthly publication. As of , articles have been published monthly, alternating between print and online-only versions print issues are available in February, April, June, August, October, and December; online-only issues are produced in January, March, May, July, September, and November. In , the journal launched an ahead-of-print publishing strategy, in which accepted manuscripts are published electronically on our website and cited on PubMed ahead of their official issue-based publication date. CUAJ covers a broad range of urological topics — oncology, pediatrics, transplantation, endourology, female urology, infertility, and more.

Percy x reyna

While this survey provides a wealth of information about urologists and their practices in Canada, with a relatively low margin of error, there are limitations that must be acknowledged. The site is secure. Zakaria, Walid Shahrour, Hazem Elmansy. F African-American men have a higher incidence of prostate cancer, increased prostate cancer mortality, and earlier age of diagnosis compared to Caucasian-American men; however, the effects of earlier or more intensive screening on cancer outcomes and on screening-related harms in African-American men remain unclear. Participants were asked whether their practices were currently hiring or expecting to hire additional urologists within the next five years. The measurement of percent free PSA has been studied as a risk-stratifying tool aimed at distinguishing men at risk from prostate cancer vs. In Memoriam — Dr. In Memoriam — Dr. Thus, prostate risk calculators can be used to estimate the risk of clinically significant prostate cancer in men presenting with an elevated PSA. Sports and the solitary kidney — What primary caregivers of a young child with a single kidney should know update , October For this reason, patients should be made aware of the risks and benefits of biopsy avoidance when mpMRI is negative. Cancer Epidemiol Biomarkers Prev. Areas of clinical practice focus are listed in Figure 3. The average time participants spent on a new patient consult was 17 minutes. The Canadian Urological Association CUA does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals.

Federal government websites often end in. The site is secure. Preview improvements coming to the PMC website in October

Published: MIS: minimally invasive surgery. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: A prospective, multicenter clinical study. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: Implications for staging. Randomized prostate cancer screening trial: year followup. Focal therapy options for treating prostate cancer were more available in the Prairies. Introduction Prostate cancer remains the most commonly diagnosed non-cutaneous malignancy among Canadian men and is the third leading cause of cancer-related death. Trends in United States prostate cancer incidence rates by age and stage, — Trained methodologists implemented the specific search strategy and two authors reviewed the titles and abstracts of potential studies to identify their relevance for full-text review. Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer.